Why the study?
Does epinephrine added to local anesthetic reduce pocket hematoma in patients undergoing pacemaker implantation?
Does epinephrine added to local anesthetic reduce pocket hematoma in patients undergoing pacemaker implantation?
The use of local epinephrine during pacemaker implantation paradoxically increases the risk of pocket hematoma, likely by masking diffuse bleeding and preventing appropriate drainage.
Answers are grounded in this paper and cite their sources.
First trial of epinephrine for pocket hematoma prevention; leaves open its role in antithrombotic patients pending larger RCTs.
Pocket hematoma (PH) is a common complication of implantations of cardiac electrophysiological devices with occurring at a particularly high rate in patients on oral anticoagulation or antiplatelet treatment. Different pharmacological agents with hemostatic effect are used to avoid PH. We supposed that the vasoconstrictor effects of epinephrine may reduce bleeding extent and be effective in prevention of PH. Maitre is the first clinical trial conducted with an aim to show the safety and efficacy of epinephrine in PH prophylaxis. We randomized 133 patients to receive either epinephrine or saline solution, which were added to a local anesthetic administered during pacemaker implantation. In cases of diffuse bleeding a method of pocket drainage was effectively used. Results showed that risk of PH was significantly higher in the group receiving epinephrine. We conclude that a local epinephrine effect may lead to a false impression of adequate hemostasis and force a surgeon to refuse from drainage insertion.
No takes yet. Share an insight, caveat, or question.
Илов et al. (2016) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: